Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
JAK2 inhibitor ruxolitinib shows promise in treating CMML patients

JAK2 inhibitor ruxolitinib shows promise in treating CMML patients

Study: New cases of cancer rising globally, but death rates falling in many countries

Study: New cases of cancer rising globally, but death rates falling in many countries

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

Amgen to present clinical data on multiple blood cancer treatments at EHA 2015

GFG's 'A Bite for the Fight' campaign raises over $1 million for The Leukemia & Lymphoma Society

GFG's 'A Bite for the Fight' campaign raises over $1 million for The Leukemia & Lymphoma Society

TGen and Baylor partnership set to increase treatment options for cancer patients

TGen and Baylor partnership set to increase treatment options for cancer patients

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Researchers discover how and where chromosome fragile sites occur in human DNA

Researchers discover how and where chromosome fragile sites occur in human DNA

Chemical drug safely controls side effects associated with haploidentical stem cell transplantation

Chemical drug safely controls side effects associated with haploidentical stem cell transplantation

Researchers explore how low-level electrical stimulation reduces inflammation

Researchers explore how low-level electrical stimulation reduces inflammation

Researchers submit patent application for drug that could destroy acute lymphoblastic leukemia

Researchers submit patent application for drug that could destroy acute lymphoblastic leukemia

Childhood cancer survivors more likely to be obese than healthy peers

Childhood cancer survivors more likely to be obese than healthy peers

MD Anderson researchers discover link between telomere degeneration and MDS

MD Anderson researchers discover link between telomere degeneration and MDS

New study finds link between father's age at birth and child's risk of blood cancer as an adult

New study finds link between father's age at birth and child's risk of blood cancer as an adult

Dana-Farber/Boston Children's joins immunotherapy clinical trial for children with ALL

Dana-Farber/Boston Children's joins immunotherapy clinical trial for children with ALL

Researchers identify promising combination strategy for treating glioblastomas

Researchers identify promising combination strategy for treating glioblastomas

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

New edition of WHO Essential Medicines List includes new treatments for hepatitis C, cancers and multi-drug TB

Overexpression of cyclin E protein could lead to breast cancer, leukemia

Overexpression of cyclin E protein could lead to breast cancer, leukemia

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

WHO moves to improve access to lifesaving medicines for hepatitis C, Drug-resistant TB and cancers

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

Quest Diagnostics launches genomic test service that aids in diagnosis for myeloid neoplasms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.